Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 301–400 of 1,001
Frye, C. A., & Wawrzycki, J. M. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(03)00159-4 · Cited by 149
“Depression among people is characterized by hyperactivity of the HPA axis (Arborelius et al., 1999; Heim et al., 2000; Nemeroff et al., 1984).”
BackgroundThe brain as a target for adrenocortical steroids: Cognitive implications
Martignoni, E., Costa, A. C., Sinforiani, E., Liuzzi, A., Chiodini, P. G., Mauri, M. F., Bono, G. G., & Nappi, G. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90040-e · Cited by 157
Morley, J. E., Mooradian, A. D., Silver, A. J., Heber, D., & Alfin-Slater, R. B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-890 · Cited by 125
Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132
Hypercortisolism Among Socially Subordinate Wild Baboons Originates at the CNS Level
Sapolsky, R. M. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110089012 · Cited by 132
Glucocorticoids, epigenetic control and stress resilience
Reul, J. M. H. M., Collins, A., Saliba, R. S., Mifsud, K. R., Carter, S. D., Gutierrez-Mecinas, M., Qian, X., & Linthorst, A. C. E. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.10.001 · Cited by 124
“In some post-mortem studies on people with a history of major depressive illness, increased levels of CRF concentrations in cerebrospinal fluid and decreased levels of CRFbinding capacity has been shown (Nemeroff et al., 1984, 1988; Swaab et al., 2005).”
BackgroundBruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 140
Keen-Rhinehart, E., Michopoulos, V, Toufexis, D. J., Martin, E. I., Nair, H., Ressler, K. J., Davis, M., Owens, M. J., Nemeroff, C. B., & Wilson, M. E. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.91 · Cited by 127
Self-citationHPA axis dysregulation in mice overexpressing corticotropin releasing hormone
Groenink, L., Dirks, A., Verdouw, P. M., Schipholt, M. L., Veening, J. G., van der Gugten, J., & Olivier, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01334-3 · Cited by 140
Psychosocial Influences on Cancer Incidence and Progression
Spiegel, D., & Kato, P. M. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609030518 · Cited by 126
Gaab, J. (2002) · Psychosomatic Medicine · doi:10.1097/01.psy.0000038937.67401.61 · Cited by 127
“Indirect support for this assumption can be derived from contrasting responses to the selective serotonergic agonist D-fenfluramine in CFS and syndromes associated with CRH hypersecretion (62, 63).”
BackgroundSensitivity to stress: Dysregulation of CRF pathways and disease development
Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 135
Kuroda, Y., Mikuni, M., Ogawa, T., & Takahashi, K. (1992) · Psychopharmacology · doi:10.1007/bf02245281 · Cited by 127
“The levels of corticotropin-releasing factor (CRF) in the cerebrospinal fluid (CSF) are higher in depressed patients than in control subjects (Nemeroff et al. 1984).”
Psychopharmacology and Cardiovascular Disease
Piña, I. L., Di Palo, K. E., & Ventura, H. O. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.458 · Cited by 126
“However, there are also physiological changes, such as hypercortisolemia and a lower than expected response to corticotropin-releasing factor administration (5,6).”
BackgroundAnxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450
Chaki, S., Nakazato, A., Kennis, L. E. J., Nakamura, M., Mackie, C. E., Sugiura, M., Vinken, P., ASHTON, D. S., Langlois, X., & Steckler, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.032 · Cited by 132
Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions
Bakshi, V. P., & Kalin, N. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01082-9 · Cited by 139
“It was initially found that depressed patients have elevated levels of cerebrospinal fluid (CSF) CRH relative to control subjects (Nemeroff et al 1984), an observation that has been replicated in a number of studies (Arato et al 1986; Banki et al 1987; France et al 1988; Widerlov et al 1988).”
From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 146
Dexamethasone for the treatment of depression: a randomized, placebo- controlled, double-blind trial
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.265 · Cited by 128
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Caldecott‐Hazard, S., Morgan, D. G., DeLeon‐Jones, F., Overstreet, D. H., & Janowsky, D. (1991) · Synapse · doi:10.1002/syn.890090404 · Cited by 124
“levels of CRH in the CSF as compared with normals (Kilts et al., 1987; Nemeroff et al., 1984).”
ResultGreen, M. K., Rani, C. S. S., Joshi, A., Soto-Piña, A. E., Martinez, P. A., Frazer, A., Strong, R., & Morilak, D. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.041 · Cited by 124
Biochemical markers subtyping major depressive disorder
Kunugi, H., Hori, H., & Ogawa, S. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12299 · Cited by 114
Chronically Restricted or Disrupted Sleep as a Causal Factor in the Development of Depression
Meerlo, P., Havekes, R., & Steiger, A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_367 · Cited by 130
Brain mechanisms underlying emotional alterations in the peripartum period in rats
Neumann, I. D. (2003) · Depression and Anxiety · doi:10.1002/da.10070 · Cited by 121
Kalin, N. H., Shelton, S. E., & Davidson, R. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00256-5 · Cited by 137
Nousen, E. K., Franco, J. G., & Sullivan, E. L. (2013) · Neuroendocrinology · doi:10.1159/000355632 · Cited by 123
Noradrenaline in mood and anxiety disorders: basic and clinical studies
Brunello, N., Blier, P., Judd, L. L., Mendlewicz, J., Nelson, C. J., Souery, D., Zohar, J., & Racagni, G. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00001 · Cited by 121
“For example, the level of corticotrophinreleasing factor (Nemeroff et al., 1984) or brain-derived neurotrophic factor in the brain has been implicated in the action of antidepressant drugs (Duman, 1998).”
BackgroundStapelberg, N. J. C., Neumann, D. L., Shum, D. H. K., McConnell, H., & Hamilton-Craig, I. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.570427 · Cited by 116
“paraventricular nucleus of the hypothalamus, supporting the hypothesis of an upregulation of the HPA axis in depression[153-156].”
BackgroundMood-stabilizing drugs: mechanisms of action
Schloesser, R. J., Martinowich, K., & Manji, H. K. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.009 · Cited by 136
Mitochondria and the economy of stress (mal)adaptation
Morava, É., & Kozicz, T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.005 · Cited by 128
Pathophysiology of HPA axis abnormalities in patients with major depression: an update
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.3.311 · Cited by 123
Berridge, C. W., & Dunn, A. J. (1987) · Hormones and Behavior · doi:10.1016/0018-506x(87)90023-7 · Cited by 127
Geriatric depression and vascular diseases: what are the links?
Camus, V., Kraehenbühl, H., Preisig, M., Büla, C., & Waeber, G. (2003) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.08.003 · Cited by 128
Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress
Coste, S. C., Murray, S., & Stenzel‐Poore, M. P. (2001) · Peptides · doi:10.1016/s0196-9781(01)00386-2 · Cited by 126
Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 133
Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder
Kang, H. J., Adams, D. H., Simen, A., Simen, B. B., Rajkowska, G., Stockmeier, C. A., Overholser, J. C., Meltzer, H. Y., Jurjus, G. J., Konick, L. C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4083-07.2007 · Cited by 119
“Moreover, previous studies have demonstrated that levels of CRH immunoreactivity are increased in the CSF of depressed subjects (Nemeroff et al., 1984), and postmortem studies report decreased levels of CRH receptor binding in cerebral cortex of suicide subjects (Nemeroff et al., 1988).”
BackgroundInfluentialModulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress
Fuchs, E., & Flügge, G. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)e0006-u · Cited by 118
Binder, E. B., Künzel, H. E., Nickel, T., Kern, N., Pfennig, A., Majer, M., Uhr, M., Ising, M., & Holsboer, F. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.018 · Cited by 99
“…neuropeptides intravenously (von Bardeleben et al., 1985) as well as postmortem in situ hybridization studies and receptor binding studies, CSF analyses and animal experiments (Nemeroff et al., 1984, 1988; Raadsheer et al., 1994; Purba et al., 1996; Keck et al., 2002, 2003; Merali et al., 2006).”
Wichers, M., Kenis, G., Koek, G. H., Robaeys, G., Nicolson, N. A., & Maes, M. H. J. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.09.007 · Cited by 135
“Depressed patients exhibit elevated CSF CRH concentrations [19], a blunted ACTH response after intravenous administration of CRH [20,21].”
BackgroundMiyata, S., Koyama, Y., Takemoto, K., Yoshikawa, K., Ishikawa, T., Taniguchi, M., Inoue, K., Aoki, M., Hori, O., Katayama, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019859 · Cited by 116
“Dysregulation of this negative feedback mechanism is reported in patients with major depressive disease, which results in hyperactivity of the HPA axis and higher basal levels of serum corticosterone [7,8].”
The impact of malnutrition on the quality of life in the elderly
Vetta, F., Ronzoni, S., Taglieri, G., & Bollea, M. R. (1999) · Clinical Nutrition · doi:10.1016/s0261-5614(98)80022-8 · Cited by 128
Muglia, L. J., Jacobson, L., Weninger, S. C., Luedke, C. E., Bae, D. S., Jeong, K. H., & Majzoub, J. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119487 · Cited by 115
“Major depressive illness, for example, is characterized by elevated glucocorticoid levels during the diurnal nadir of adrenocortical activity (25, 26), which are associated with elevations in cerebrospinal fluid CRH concentrations (27).”
BackgroundGrabe, H. J., Schwahn, C., Appel, K., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Barnow, S., Lucht, M., Freyberger, H. J., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31131 · Cited by 110
“In addition, elevated CRH concentrations in the cerebrospinal fluid and altered CRHR1 messenger RNA expression were found in depressed patients [Nemeroff et al., 1984; Merali et al., 2004].”
BackgroundOpen questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 109
“This is associated British Journal of Pharmacology (2010) 159 1187–1200 with increased concentrations of CRF in the cerebrospinal fluid (Nemeroff et al., 1984), increased adrenocorticotropin (ACTH) pulse frequency (Mortola et al., 1987), blunted ACTH response following CRF administration (Gold et…”
BackgroundA study on the blunted natural killer cell activity in severely depressed patients
Maes, M. H. J., Stevens, W. J., Peeters, D., DeClerck, L., Scharpé, S., Bridts, C. H., Schotte, C., & Cosyns, P. R. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90390-b · Cited by 115
Are Stress-Induced Cortisol Changes During Pregnancy Associated With Postpartum Depressive Symptoms?
Nierop, A., Bratsikas, A., Zimmermann, R., & Ehlert, U. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000244385.93141.3b · Cited by 107
Bangasser, D. A. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-2 · Cited by 107
“High levels of CRF are found in the cerebral spinal fluid and brain regions of patients with depression and PTSD, and these levels are reduced with antidepressant treatment [70-83].”
BackgroundFriedmann, E. (2006) · Elsevier eBooks · doi:10.1016/b978-012369484-3/50005-0 · Cited by 115
The hypothalamic–pituitary–gonadal axis in mood disorders
Young, E. A., & Korszun, A. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00002-0 · Cited by 127
“In common with the findings in these syndromes, weight loss and HPA axis overactivity are frequent findings in major depression, and increased cerebrospinal fluid levels of CRH have been reported in both depression and anorexia nervosa [37,50].”
BackgroundGold, P. W., Gabry, K. E., Yasuda, M. R., & Chrousos, G. P. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00022-6 · Cited by 122
The role of Corticotropin Releasing Factor in Depressive Illness: a Critical Review
Mitchell, A. J. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00059-6 · Cited by 125
Stress, Depression and the Activation of the Immune System
Leonard, B. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150562 · Cited by 112
Pharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113
Suicide: A Four‐pathway Clinical‐Biochemical Model
FAWCETT, J., BUSCH, K. A., JACOBS, D., KRAVITZ, H. M., & FOGG, L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52366.x · Cited by 105
Binder, E. B., Owens, M. J., Liu, W., Deveau, T. C., Rush, A. J., Trivedi, M. H., Fava, M., Bradley, B., Ressler, K. J., & Nemeroff, C. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.18 · Cited by 111
Self-citationThe Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 112
“In depressed patients, several studies have reported elevated levels of CRH in cerebrospinal fluid (CSF), which then return to normal after successful therapy with antidepressant drugs or electroconvulsive shock (ECS) (2,137,139).”
BackgroundEndocrine disturbances in depression
Tichomirowa, M. A., Keck, M. E., Schneider, H. J., Páez-Pereda, M., Renner, U., Holsboer, F., & Stalla, G. K. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345535 · Cited by 118
Brown, A. D. H., Barton, D. A., & Lambert, G. W. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00004 · Cited by 122
Costa, A. C., Bono, G., Martignoni, E., Merlo, P., Sances, G., & Nappi, G. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(96)00001-7 · Cited by 120
Chen, Y. L., Mansbach, R. S., Winter, S. M., Brooks, E., Collins, J., Corman, M. L., Dunaiskis, A. R., Faraci, W. S., Gallaschun, R. J., Schmidt, A., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960861b · Cited by 112
Low natural killer cytotoxicity in major depression
Irwin, M. R., Smith, T. L., & Gillin, J. C. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90531-5 · Cited by 112
Egawa, M., Yoshimatsu, H., & Bray, G. A. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90181-3 · Cited by 112
Regulation of 5‐HT receptors by corticosteroids: where do we stand?
Chaouloff, F. (1995) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00289.x · Cited by 112
Kimura, M., Müller-Preuss, P., Lu, A., Wiesner, E., Flachskamm, C., Wurst, W., Holsboer, F., & Deussing, J. M. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.46 · Cited by 111
Scott, L. V., & Dinan, T. G. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00101-8 · Cited by 118
Geracioti, T. D. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.6.1325 · Cited by 112
Self-citationMárquez, C., & Armario, A. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90182-x · Cited by 111
Central corticotropin-releasing factor suppresses natural killer cytotoxicity
Irwin, M. R., Vale, W., & Britton, K. T. (1987) · Brain Behavior and Immunity · doi:10.1016/0889-1591(87)90009-2 · Cited by 114
Self-citationBlockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat
Chang, F.-C., & Opp, M. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.3.r793 · Cited by 112
Sullivan, N. R., & de Kar, L. D. V. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01006-9 · Cited by 128
Neurokinin1 Receptor Antagonists as Potential Antidepressants
Stout, S. C., Owens, M. J., & Nemeroff, C. B. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.877 · Cited by 110
Self-citationTreating Impulsivity and Anxiety in the Suicidal Patient
Fawcett, J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05800.x · Cited by 107
Branchi, I., Santarelli, S., Capoccia, S., Poggini, S., D’Andrea, I., Cirulli, F., & Alleva, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062226 · Cited by 102
“, loss of interest or pleasure in normal activities -- one of the nine symptoms defined by the Diagnostic and Statistic Manual (DSM-IVTR) for major depression, which has been successfully translated in mice [24]; (b) BDNF levels, reported to be reduced in depressed patients [25,26] and increased by antidepressant admi…”
BackgroundCognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
“For example, MDD is associated with increased levels of cortisol [79], an impaired dexamethasone suppression test [79], elevated basal CRH levels in the cerebrospinal fluid (CSF) [80] as well as increased sizes and activities of the pituitary and adrenal glands [81].”
BackgroundKehne, J. H., & Cain, C. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.011 · Cited by 105
“…are reported to be elevated in at least some depressed patients (Nemeroff et al., 1984; Nemeroff, 1992) and a correlation to a blunted ACTH response to IV-administered CRF is cited as evidence suggestive of a coordinated hyperactivation of HPA and nonHPA axis CRF pathways (Newport et al., 2003).”
BackgroundBruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301192 · Cited by 110
“Second, clinical studies indicate that brain CRF systems are hyperactive in patients with depressive disorders (De Bellis et al, 1993; Merali et al, 2004; Nemeroff et al, 1984, 1991; Veith et al, 1993; Zobel et al, 2000).”
BackgroundNikisch, G., Mathé, A. A., Czernik, A., Thiele, J., Bohner, J., Eap, C. B., Ågren, H., & Baumann, P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0034-3 · Cited by 117
“…urine and cerebrospinal fluid (CSF), abnormal 24-h pattern of adrenocorticotrophic hormone (AC TH) and cortisol secretion, and elevated levels of corticotropin-releasing hormone (CRH) in cerebrospinal fluid (Holsboer et al. 1985; Linkowski et al. 1985; Nemeroff et al. 1984; Nikisch et al. 2004).”
BackgroundSartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B., Brand, U., Fleischhacker, W., Goodwin, G., Grunze, H., Knapp, M., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98
Stress and Glucocorticoids in Aging
Sapolsky, R. M., Armanini, M. P., Packan, D. R., & Tombaugh, G. C. (1987) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30453-5 · Cited by 111
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients
Stelzhammer, V., Haenisch, F., Chan, M. K., Cooper, J. D., Steiner, J., Steeb, H., Martins-de-Souza, D., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000819 · Cited by 105
“These include circulating neuroendocrine hormones such as insulin, leptin, adrenocorticotrophic hormone (ACTH) and cortisol, along with numerous inflammatory factors including interleukin (IL)-1, IL-6, IL-18, interferon-gamma and tumour necrosis factor (TNF) alpha.”
BackgroundBangasser, D. A., Reyes, B. A. S., Piel, D., Garachh, V, Zhang, X.-Y., Plona, Z. M., Van Bockstaele, E. J., Beck, S. G., & Valentino, R. J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.24 · Cited by 106
Jensen, Jessop, Harbuz, Mørk, Sánchez, & Mikkelsen (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00362.x · Cited by 105
High susceptibility to chronic social stress is associated with a depression-like phenotype
Schmidt, M. V., Scharf, S. H., Sterlemann, V., Ganea, K., Liebl, C., Holsboer, F., & Müller, M. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.10.002 · Cited by 114
“Specifically the high levels of CRH are clinically relevant, as depressed patients have also been found to express high levels of CRH (Nemeroff et al., 1984; Holsboer, 2003a; Swaab et al., 2005; Heim et al., 2008).”
BackgroundRamasubbu, R. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00244-x · Cited by 108
Bryce, C. A., & Floresco, S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.15 · Cited by 112
“Given that abnormal increases in central CRF activity have been implicated in the pathophysiology of depression (Nemeroff et al, 1984; Banki et al, 1987; Hauger et al, 2009; Binder and Nemeroff, 2009), the present findings provide support for the notion that aberrant hyperactive CRF transmission…”
ResultLow cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression
Geracioti, T. D., Loosen, P. T., & Orth, D. N. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00312-5 · Cited by 105
Self-citationKinlein, S. A., & Karatsoreos, I. N. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100819 · Cited by 116
“In support of this, significantly higher cerebrospinal fluid concentrations of CRH have been observed in individuals with MDD or PTSD, and reduced CRH binding sites have been observed in the frontal cortex of suicide victims [153; 154; 155].”
BackgroundChronic Stress and Individual Vulnerability
Schmidt, M. V., Sterlemann, V., & Müller, M. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.017 · Cited by 99
The impact of treatment on HPA axis activity in unipolar major depression
McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103
“…Jarrett et al., 1983); both elevated levels and blunted awakening cortisol (Huber et al., 2006); elevated concentration of cerebrospinal fluid CRF (Nemeroff et al., 1984); nonsuppression in response to dexamethasone challenge (Carroll et al., 1981); increased cortisol response to ACTH test…”
BackgroundInfluentialOn the role of corticotropin-releasing hormone receptors in anxiety and depression
Reul, J. M. H. M., & Holsboer, F. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/jreul · Cited by 103
Carbone, D. L., & Handa, R. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.073 · Cited by 111
“Following an initial report indicating a correlation between elevated CRH in the cerebrospinal fluid and the incidence of depression in humans (Nemeroff et al., 1984) came findings of increased numbers of CRH and vasopressin neurons within the postmortem hypothalamus of depressed patients (Purba et…”
BackgroundDepressive Symptoms Are Associated With Blunted Cortisol Stress Responses in Very Low-Income Women
Burke, H. M., Fernald, L. C., Gertler, P. J., & Adler, N. E. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000156939.89050.28 · Cited by 100
Anorexia in Older Persons: Epidemiology and Optimal Treatment
Morley, J. E. (1996) · Drugs & Aging · doi:10.2165/00002512-199608020-00007 · Cited by 103
Epigenetic Risk Factors in PTSD and Depression
Raabe, F. J., & Spengler, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00080 · Cited by 93
Spijker, A. T., & van Rossum, E. F. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04985.x · Cited by 102
Levant, B., Ozias, M. K., Davis, P. F., Winter, M., Russell, K. L., Carlson, S. E., Reed, G. A., & McCarson, K. E. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.06.012 · Cited by 97
“…is suggested by increased basal circulating levels of cortisol, urinary free cortisol concentrations, and the concentration of corticotrophin releasing factor (CRF) in cerebral spinal fluid (CSF) of depressed patients (Carpenter and Bunney, 1971; Carroll et al., 1976; Nemeroff et al., 1984).”
Guardiola-Diaz, H. M. (1996) · Molecular Endocrinology · doi:10.1210/me.10.3.317 · Cited by 101
HPA axis activation in major depression and response to fluoxetine: a pilot study
Young, E. A., Altemus, M. M., López, J. F., Kocsis, J. H., Schatzberg, A. F., DeBattista, C., & Zubieta, J. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.02.002 · Cited by 106
“, 1990), increased CRH in the CSF of individuals with major depression (Nemeroff et al., 1984; Roy et al., 1987), increased POMC mRNA in the pituitary (Lopez et al.”
BackgroundZuloaga, D. G., Heck, A. L., De Guzman, R. M., & Handa, R. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00319-2 · Cited by 90
“Such elevations are also associated with obesity, insulin resistance, and neurological disorders [5, 7].”
BackgroundPost, R. M., & Weiss, S. R. B. (1996) · Molecular Neurobiology · doi:10.1007/bf02740751 · Cited by 100
“Conversely, blockade of glucocorticoid excesses in depression that are presumably driven, in part, by increases in CRH (a putative "bad guy") ( Nemeroff et al., 1984; Banki et al., 1988; Arana and Forbes, 1991; McEwen et al., 1992) can improve depressed mood (Arana et al., 1995).”
BackgroundCorticotropin-releasing hormone (CRH) as a regulator of waking
Chang, F.-C., & Opp, M. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00024-0 · Cited by 99
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.